GST rates slashed for certain cancer drugs
Advertisement
New Delhi: In an effort to reduce the overall cost for the treatment of cancer, the GST Council decided to reduce the GST rate on certain cancer drugs from 12 per cent to 5 per cent in a meeting held on Monday. These drugs are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab.
In another decision, GST rate has been reduced prospectively from 18 per cent to 12 per cent for namkeens and savoury items.
For more details, click the link below:
GST rates reduced from 12 percent to 5 per cent on certain cancer drugs
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.